We also knocked down TFE3 and TFEB in lung cancer and breast cancer cells where their expression has no negative correlation with patient prognosis and it was found that alteration of the TFE3 or TFEB expression has little effect on tumour maintenance or progression (data not shown). Here, TFE3 is linked to breast carcinoma.